Jean-Pierre Tassignon
President & CEO. Jean-Pierre is an M.D. registered with the Medical Association in Belgium and is also an "Arzt" in Germany. He holds diplomas in Pharmaceutical as well as in Industrial Medicine and a postgraduate certificate in business administration. He is a Fellow of the Faculty of Pharmaceutical Medicine in London and a Member of the Belgian College of Pharmaceutical Medicine. He is a member of various professional associations.
He is Chairman of the Board of Directors of the European Forum for GCP in Brussels since 2005. He is a lecturer and examiner on the postgraduate course in pharmaceutical medicine, Pharmed, at the Free University of Brussels. He has authored many articles on original clinical research as well as clinical research methodology, including the chapter on clinical trials in Central and Eastern Europe in the "Clinical Research Manual", edited by D. Luscombe and P. Stonier, published by Euromed Communications. He is also listed as an inventor on several patents.
Jean-Pierre started his career at Solvay (1974-1988) as a Medical Toxicologist and became Counsellor in Industrial Medicine and Toxicology for the group in 1978, and Secretary of the Solvay Pharmaceutical Board and International Medical Director in 1984. From 1988 to 1992, he was Executive Vice-President Europe for Corning-Besselaar (now Covance). Prior to founding Crossover, Jean-Pierre established Tassignon & Partners SA, a consultancy specialising in drug development planning and coordination of which he was the President and CEO (1992-2003), and PSI Pharma Support International AG, of which he was Executive Vice-President from 1995 until 2003 and President until 2006.
He is Chairman of the Board of Directors of the European Forum for GCP in Brussels since 2005. He is a lecturer and examiner on the postgraduate course in pharmaceutical medicine, Pharmed, at the Free University of Brussels. He has authored many articles on original clinical research as well as clinical research methodology, including the chapter on clinical trials in Central and Eastern Europe in the "Clinical Research Manual", edited by D. Luscombe and P. Stonier, published by Euromed Communications. He is also listed as an inventor on several patents.
Jean-Pierre started his career at Solvay (1974-1988) as a Medical Toxicologist and became Counsellor in Industrial Medicine and Toxicology for the group in 1978, and Secretary of the Solvay Pharmaceutical Board and International Medical Director in 1984. From 1988 to 1992, he was Executive Vice-President Europe for Corning-Besselaar (now Covance). Prior to founding Crossover, Jean-Pierre established Tassignon & Partners SA, a consultancy specialising in drug development planning and coordination of which he was the President and CEO (1992-2003), and PSI Pharma Support International AG, of which he was Executive Vice-President from 1995 until 2003 and President until 2006.
Velizar Tchernev
International Director, Technology Division and Director South East Europe. Velizar obtained his Ph.D. in the USA and his M.D. degree in Bulgaria. Prior to joining Crossover, Velizar served as Country Manager at PSI Pharma Support International in Bulgaria, Director of Clinical Research at Genomas Inc (USA), Senior Research Scientist at Molecular Staging Inc (USA), and Research Scientist at CuraGen Corp (USA). He has extensive experience in the application of modern technology in clinical and basic research, including proteomics, genomics, bioinformatics, immunology and personalised medicine. He is an author of a number of professional articles published in leading international peer-reviewed journals. Velizar is listed as an inventor on two issued patents and more than 50 patent applications. He has received several professional awards and has been a member of a number of international professional societies and organizations.